Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective multicenter observational study of Yunnan Baiyao ointment for musculoskeletal pain
ChiCTR2500111681Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Nov 2025
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Yunnan Baiyao ointment in osteoarthritis (OA), lumbodynia (LBP), cervical osteoarthritis and 6 more (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: European Five-Dimensional Health Scale (EQ-5D) score, Time and proportion of ≥30% reduction in pain NRS score within 7 days and 7 more. Started Nov 2025; status: recruiting.
02
Drugs
Yunnan Baiyao ointment
03
Conditions
osteoarthritis (OA)lumbodynia (LBP)cervical osteoarthritisRotator cuff deficiency (RCD)adhesive capsulitis (AC)
Beyond the preview
Go deeper on ChiCTR2500111681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500111681.